These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 25187793)
21. Influence of infection on the distribution patterns of NIH-Chronic Prostatitis Symptom Index scores in patients with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). Magri V; Wagenlehner FM; Marras E; VAN Till JW; Houbiers J; Panagopoulos P; Petrikkos GL; Perletti G Exp Ther Med; 2013 Aug; 6(2):503-508. PubMed ID: 24137216 [TBL] [Abstract][Full Text] [Related]
22. Alfuzosin treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, double-blind, placebo-controlled, pilot study. Mehik A; Alas P; Nickel JC; Sarpola A; Helström PJ Urology; 2003 Sep; 62(3):425-9. PubMed ID: 12946740 [TBL] [Abstract][Full Text] [Related]
23. Treatment of refractory category III nonbacterial chronic prostatitis/chronic pelvic pain syndrome with intraprostatic injection of onabotulinumtoxinA: a prospective controlled study. Abdel-Meguid TA; Mosli HA; Farsi H; Alsayyad A; Tayib A; Sait M; Abdelsalam A Can J Urol; 2018 Apr; 25(2):9273-9280. PubMed ID: 29680006 [TBL] [Abstract][Full Text] [Related]
24. Failure of a monotherapy strategy for difficult chronic prostatitis/chronic pelvic pain syndrome. Nickel JC; Downey J; Ardern D; Clark J; Nickel K J Urol; 2004 Aug; 172(2):551-4. PubMed ID: 15247727 [TBL] [Abstract][Full Text] [Related]
25. Chronic prostatitis/chronic pelvic pain syndrome: symptoms are aggravated by cold and become less distressing with age and time. Hedelin H; Jonsson K Scand J Urol Nephrol; 2007; 41(6):516-20. PubMed ID: 17853027 [TBL] [Abstract][Full Text] [Related]
26. Fluoxetine ameliorates symptoms of refractory chronic prostatitis/chronic pelvic pain syndrome. Xia D; Wang P; Chen J; Wang S; Jiang H Chin Med J (Engl); 2011 Jul; 124(14):2158-61. PubMed ID: 21933619 [TBL] [Abstract][Full Text] [Related]
28. [Long-term effects of osteopathic treatment of chronic prostatitis with chronic pelvic pain syndrome: a 5-year follow-up of a randomized controlled trial and considerations on the pathophysiological context]. Marx S; Cimniak U; Rütz M; Resch KL Urologe A; 2013 Mar; 52(3):384-90. PubMed ID: 23354911 [TBL] [Abstract][Full Text] [Related]
29. Evaluation of psychological stress, cortisol awakening response, and heart rate variability in patients with chronic prostatitis/chronic pelvic pain syndrome complicated by lower urinary tract symptoms and erectile dysfunction. Bai J; Gu L; Chen Y; Liu X; Yang J; Li M; Dong X; Yang S; Huang B; Wang T; Jin L; Liu J; Wang S Front Psychol; 2022; 13():903250. PubMed ID: 36405196 [TBL] [Abstract][Full Text] [Related]
30. Clinical significance of national institutes of health classification in patients with chronic prostatitis/chronic pelvic pain syndrome. Sung YH; Jung JH; Ryang SH; Kim SJ; Kim KJ Korean J Urol; 2014 Apr; 55(4):276-80. PubMed ID: 24741418 [TBL] [Abstract][Full Text] [Related]
32. Efficacy of Palmitoylethanolamide, Epilobium and Calendula suppositories for the treatment of patients with chronic prostatitis/chronic pelvic pain syndrome type III. Morgia G; Lo Giudice A; Carrino M; Voce S; Cocci A; Reale G; Minervini A; Cimino S; Russo GI; Zingone F Arch Ital Urol Androl; 2024 Jun; 96(2):12582. PubMed ID: 38934521 [TBL] [Abstract][Full Text] [Related]
33. The efficacy and safety of duloxetine in a multidrug regimen for chronic prostatitis/chronic pelvic pain syndrome. Giannantoni A; Porena M; Gubbiotti M; Maddonni S; Di Stasi SM Urology; 2014 Feb; 83(2):400-5. PubMed ID: 24231216 [TBL] [Abstract][Full Text] [Related]
34. Non-pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome: a Cochrane systematic review. Franco JVA; Turk T; Jung JH; Xiao YT; Iakhno S; Garrote V; Vietto V BJU Int; 2019 Aug; 124(2):197-208. PubMed ID: 30019814 [TBL] [Abstract][Full Text] [Related]
35. Clinical study of duloxetine hydrochloride combined with doxazosin for the treatment of pain disorder in chronic prostatitis/chronic pelvic pain syndrome: An observational study. Zhang M; Li H; Ji Z; Dong D; Yan S Medicine (Baltimore); 2017 Mar; 96(10):e6243. PubMed ID: 28272220 [TBL] [Abstract][Full Text] [Related]
37. Optimal acupoint and session of acupuncture for patients with chronic prostatitis/chronic pelvic pain syndrome: a meta-analysis. Zhang W; Fang Y; Shi M; Zhang M; Chen Y; Zhou T Transl Androl Urol; 2021 Jan; 10(1):143-153. PubMed ID: 33532304 [TBL] [Abstract][Full Text] [Related]
38. A phase II, randomized, single-blinded, placebo-controlled clinical trial on the efficacy of Curcumina and Calendula suppositories for the treatment of patients with chronic prostatitis/chronic pelvic pain syndrome type III. Morgia G; Russo GI; Urzì D; Privitera S; Castelli T; Favilla V; Cimino S Arch Ital Urol Androl; 2017 Jun; 89(2):110-113. PubMed ID: 28679180 [TBL] [Abstract][Full Text] [Related]
39. Seasonal changes in symptoms in patients with chronic prostatitis/chronic pelvic pain syndrome: a seasonal follow-up study. Shin JH; Lee G Scand J Urol; 2014 Dec; 48(6):533-7. PubMed ID: 25012875 [TBL] [Abstract][Full Text] [Related]
40. Relationship between premature ejaculation and chronic prostatitis/chronic pelvic pain syndrome. Lee JH; Lee SW J Sex Med; 2015 Mar; 12(3):697-704. PubMed ID: 25475760 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]